Pharmacovigilance of Vaccines in the USA (US FDA)
US FDA Pharmacovigilance Requirements for Drugs in the USA
Microbiome Based Therapies : Regulations and Market Outlook
US FDA Regulation of Nitrosamines in the USA
Biopharmaceutical Alliance Launched by India, South Korea, US, Japan, and EU
Case Study: Nitrosamine Impurities Analysis - Artixio’s Strategic Staffing Solutions for a Generic Drug Manufacturer based in the USA
FAQs - Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
US FDA Guidance on Registration and Listing of Cosmetic Products and Facilities under Modernization of Cosmetics Regulation Act (MoCRA)
US FDA’s final guidance on Digital Health Technologies for Clinical Investigations
US FDA Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
The Q-Submission Meetings for Medical Devices with US FDA
US FDA RFD and Pre-RFD Submissions for Combination Products in USA
Medical Device Registration in USA : 510(k) Registration with US FDA
Medical Device Registration in USA by US Food and Drug Administration (US FDA)
The US Agent: Your Essential Partner for FDA Regulatory Success
Biologics and Biosimilars Regulations, Registration Process in the USA (FDA)
Expanded Access by USA FDA for Investigational Drugs
Insights
Global, Concurrent, Experience Based
Deep dive and engage in insightful discourse driven by concurrent global regulatory scenarios, industry trends and Artixio’s real-time experience across the product value chain. Whitepapers, research articles, landscape reports and case studies to help you stay ahead of the curve.
